#pharmacokinetics — Tuesday, April 07, 2026 (1 items)
| 0 | 💬 0 |
Safety, Pharmacokinetics, and Pharmacodynamics of Single-Dose Programmed Cell Death Protein 1 Inhibitor, Budigalimab, in People With HIV-1 With Antiretroviral Therapy-Suppressed Viral Load.
(academic.oup.com)
|
Journal of Infectious Diseases 2026-04-07 | #pharmacokinetics #antibody #clinical trial #immunotherapy #hiv |